Patent Assignment
Reel/Frame 055970/0232
Assignment of Assignor's Interest
Recorded: 2021-04-20
Pages: 9
Assignors
MASUMOTO, SHUJI
Executed: 2019-12-13
TANAKA, HIROAKI
Executed: 2019-12-13
KUREBAYASHI, HIROTAKA
Executed: 2019-12-17
HASHIZUKA, TAKAHIKO
Executed: 2019-12-16
ARIKAWA, YUKA
Executed: 2019-12-12
Assignee
SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
6-8, DOSHO-MACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property
(1)
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 20, 2021
From: SIDDIQUI-JAIN, ADAM; FLYNN, PAUL; FUJIWARA, YUJI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 055969/0628 →
Assignment of Assignor's Interest
Apr 20, 2021
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 055970/0580 →
Merger
Apr 20, 2021
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 055970/0691 →
Change of Name
Apr 20, 2021
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 056065/0276 →
Change of Name
Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →